The Gly460Trp variant of alpha-adducin is not associated with hypertension in white Anglo-Australians

Am J Hypertens. 1999 Jun;12(6):632-6. doi: 10.1016/s0895-7061(99)00004-7.

Abstract

A Gly460Trp variant of the cytoskeletal protein alpha-adducin has recently been implicated in the etiology of essential hypertension (HT) in a study involving southern European whites. We attempted to replicate this finding in a well-characterized, extensively studied group of 112 white Australians with essential HT, with strong family history (two HT parents), early-onset, moderate to severe disease, and of British extraction. Controls were 196 normotensive (NT) white subjects whose parents were both NT older than age 50 years. A mismatch polymerase chain reaction method involving BanII was developed for genotyping. Frequency of the Trp460 allele was 0.23 in the HT and 0.24 in the NT groups (chi2 = 0.2, P = .7). No association was observed with blood pressure, body mass index, age, plasma renin, angiotensinogen, angiotensin converting enzyme, cholesterol, triglycerides, or HDL or LDL cholesterol. Our results therefore provide no support for a role for the alpha-adducin variant in hypertension, at least in our severely affected Anglo-white group with strong family history of HT.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Angiotensinogen / blood
  • Australia
  • Calmodulin-Binding Proteins / genetics*
  • Cytoskeletal Proteins / genetics*
  • Female
  • Genotype
  • Humans
  • Hypertension / genetics*
  • Hypertension / metabolism
  • Lipids / blood
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / blood
  • Polymorphism, Genetic
  • Renin / blood
  • White People

Substances

  • Calmodulin-Binding Proteins
  • Cytoskeletal Proteins
  • Lipids
  • adducin
  • Angiotensinogen
  • Peptidyl-Dipeptidase A
  • Renin